Get the Stockscreener App
10.98
1.70%
-0.19
After Hours:
10.98
Dynavax Technologies Corp stock is traded at $10.98, with a volume of 1.21M.
It is down -1.70% in the last 24 hours and up +10.69% over the past month.
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
See More
Previous Close:
$11.17
Open:
$11.06
24h Volume:
1.21M
Relative Volume:
0.66
Market Cap:
$1.32B
Revenue:
$260.81M
Net Income/Loss:
$20.48M
P/E Ratio:
84.46
EPS:
0.13
Net Cash Flow:
$22.67M
1W Performance:
-1.61%
1M Performance:
+10.69%
6M Performance:
-15.86%
1Y Performance:
-1.88%
1-Day Range:
$10.67
$11.28
1-Week Range:
$10.67
$11.44
52-Week Range:
$9.22
$14.63
Dynavax Technologies Corp Stock (DVAX) Company Profile
Name
Dynavax Technologies Corp
Sector
Phone
(510) 848-5100
Address
2100 POWELL STREET, EMERYVILLE, CA
Compare DVAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
10.98 | 1.34B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | Goldman | Neutral → Sell |
| Feb-01-24 | Initiated | Goldman | Neutral |
| Sep-27-22 | Initiated | JMP Securities | Mkt Outperform |
| Jan-06-22 | Resumed | Goldman | Buy |
| Aug-06-21 | Initiated | Goldman | Buy |
| Aug-07-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-03-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-15-20 | Initiated | Evercore ISI | Outperform |
| Oct-18-19 | Initiated | H.C. Wainwright | Buy |
| Jul-11-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-27-19 | Reiterated | Cantor Fitzgerald | Overweight |
| May-10-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-08-18 | Reiterated | Cantor Fitzgerald | Overweight |
| Feb-14-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-25-17 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-15-17 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-31-17 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-31-17 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Apr-28-16 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Apr-27-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Initiated | RBC Capital Mkts | Outperform |
| Nov-25-13 | Upgrade | MLV & Co | Hold → Buy |
| Feb-25-13 | Downgrade | MLV & Co | Buy → Hold |
| Nov-16-12 | Reiterated | MLV & Co | Buy |
View All
Dynavax Technologies Corp Stock (DVAX) Latest News
Does Dynavax Technologies Corporation show high probability of reboundRSI Divergence and Support Breakout Analysis - Newser
Using Python tools to backtest Dynavax Technologies Corporation strategiesRisk Managed Watchlist with Breakout Picks - Newser
What makes Dynavax Technologies Corporation stock price move sharplyAI Stock Movement Forecast with Accuracy - Newser
Victory Capital Management Inc. Sells 32,496 Shares of Dynavax Technologies Corporation (NASDAQ:DVAX) - Defense World
Will Dynavax Technologies Corporation outperform the marketGrowth Watchlist for Long Term Positioning - Newser
Real time pattern detection on Dynavax Technologies Corporation stockSafe Entry Zone Based on Chart Analysis - Newser
Has Dynavax Technologies Corporation formed a bullish divergenceFree Trade Ready Stock Watch for Short Term - Newser
Why Dynavax Technologies Corporation stock attracts strong analyst attentionHigh Return Trade Roadmap with Setup Filters - Newser
Historical volatility pattern of Dynavax Technologies Corporation visualizedFree Stock Selection With High Accuracy - Newser
How Resilient Is Dynavax Technologies Corporation Stock During Economic DownturnsEarnings Impact and Stock Reaction Analysis - Newser
Quant Strategy Flags Dynavax Technologies Corporation for EntryLow Risk Buy Zone Opportunity Watch Ongoing - metal.it
Custom watchlist performance reports with Dynavax Technologies CorporationWeekly Trend Watch with Market Signals - Newser
How does Dynavax Technologies Corporation compare to its industry peersFree Stock Market Trend Analysis - jammulinksnews.com
How many analysts rate Dynavax Technologies Corporation as a “Buy”Skyrocketing returns - jammulinksnews.com
What are the latest earnings results for Dynavax Technologies CorporationSuperior investment outcomes - jammulinksnews.com
Is it the right time to buy Dynavax Technologies Corporation stockRapid profit acceleration - jammulinksnews.com
Published on: 2025-07-27 19:32:04 - jammulinksnews.com
What drives Dynavax Technologies Corporation stock priceFree Stock Market Query - Autocar Professional
How high can Dynavax Technologies Corporation stock price go in 2025Strongest growth potential - jammulinksnews.com
Bank of New York Mellon Corp Has $11.56 Million Position in Dynavax Technologies Corporation (NASDAQ:DVAX) - Defense World
Dynavax Technologies Corporation Stock Analysis and ForecastMarket-leading growth rates - jammulinksnews.com
what makes dynavax technologies corporation stock price move sharplyFree Stock Market Insider Analysis - Newser
US FDA approves pre-filled version of GSK's shingles vaccine - Reuters
Principal Financial Group Inc. Purchases 19,830 Shares of Pitney Bowes Inc. (NYSE:PBI) - Defense World
Principal Financial Group Inc. Has $7.92 Million Stake in Dynavax Technologies Corporation (NASDAQ:DVAX) - Defense World
How Dynavax Technologies Corporation stock performs during market volatilityFree Stock Index Interpretation - Newser
Cambridge Investment Research Advisors Inc. Makes New $312,000 Investment in Dynavax Technologies Corporation (NASDAQ:DVAX) - Defense World
GAMMA Investing LLC Increases Stake in Dynavax Technologies Corporation (NASDAQ:DVAX) - Defense World
Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31 - Insider Monkey
13 Best Pharma Stocks to Buy According to Wall Street Analysts - Insider Monkey
State of Alaska Department of Revenue Has $878,000 Stock Position in Dynavax Technologies Corporation (NASDAQ:DVAX) - Defense World
Is Dynavax Technologies Corp. overvalued or undervalued? - MarketsMojo
Dynavax’s SWOT analysis: heplisav-b maker’s stock rises on strong sales - Investing.com Canada
Dynavax stock rating reiterated at Market Outperform by Citizens JMP - Investing.com
Dynavax Technologies Corp (DVAX) Trading 3.7% Higher on Jun 18 - GuruFocus
Declaration of Voting Results by Dynavax Technologies - MarketScreener
Dynavax Technologies Co. (NASDAQ:DVAX) Shares Bought by GAMMA Investing LLC - Defense World
Dynavax elects all four of its nominees after Deep Track proxy fight - Reuters
Dynavax (DVAX) Maintains Board Against Deep Track's Efforts - GuruFocus
Dynavax shareholders Reject Deep Track Capital, LP's Director Nominees - marketscreener.com
Dynavax shareholders reject activist's director slateSan Francisco Business Times - The Business Journals
Dynavax stockholders elect all company director nominees at annual meeting By Investing.com - Investing.com Canada
Dynavax stockholders elect all company director nominees at annual meeting - Investing.com
Dynavax Technologies Corp Stock (DVAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):